Summary
- Current Price
- As of today, COGT price is $37.93, up +1.66% on
- Current Price All-Time High
- COGT price is currently -46.31% below its historical high of $70.64 set on
- Market Cap
- COGT current market cap is $7B, up +393.03% over the past 365 days
- Revenue
- COGT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for COGT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cogent Biosciences, Inc. |
| Ticker | NASDAQ: COGT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cogentbio.com |
| Employees | 205 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $37.93 | |
| Price, 1D Change | +1.66% | |
| $7B | ||
| - | ||
| - | ||
| 2.40 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.55 | ||
| EPS, 1Y Change | -3.61% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | UMRX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.55 | ||
| EPS Estimate | -$2.21 | N/A |
| EPS Est. Change | +13.15% | N/A |
| $0.00 | ||
| Revenue Estimate | $5.56M | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $37.93 | |
| Price Target | $55.00 | - |
| Price Tgt. Change | +45.00% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.40 | -$2.46 | -2.48% | |
| -$2.23 | -$2.55 | -14.34% | |
| -$2.21 | N/A | +13.15% | |
| -$1.13 | N/A | +55.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $5.56M | N/A | - | |
| $309.21M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $37.93 | |
| $35.85 | ||
| $37.69 | ||
| $33.17 | ||
| $38.43 | ||
| $0.34 | ||
| 2.40 | ||
| $2.05 | ||
| 44.68 | ||
| 75.12% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.55 | ||
| $0.00 | ||
| - | ||
| -$333.36M | ||
| - | ||
| -$328.94M | ||
| - | ||
| -$328.74M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 14.23 | ||
| 14.23 | ||
| - | ||
| - | ||
| 11.25 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 12.12 | ||
| -16.66 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $546.98M | ||
| $900.77M | ||
| $937.61M | ||
| $910.36M | ||
| $301.24M | ||
| $63.95M | ||
| $238.80M | ||
| $1.55M | ||
| $9.50M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $328.94M | ||
| $333.36M | ||
| $0.00 | ||
| $0.00 | ||
| $4.58M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$264.44M | ||
| -$399.53M | ||
| $878.23M | ||
| $1.55M | ||
| -$266.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Guggenheim | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| Piper Sandler | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| Needham | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with COGT
FAQ
- What is the ticker symbol for Cogent Biosciences, Inc.?
- The ticker symbol for Cogent Biosciences, Inc. is NASDAQ:COGT
- Does Cogent Biosciences, Inc. pay dividends?
- No, Cogent Biosciences, Inc. does not pay dividends
- What sector is Cogent Biosciences, Inc. in?
- Cogent Biosciences, Inc. is in the Healthcare sector
- What industry is Cogent Biosciences, Inc. in?
- Cogent Biosciences, Inc. is in the Biotechnology industry
- What country is Cogent Biosciences, Inc. based in?
- Cogent Biosciences, Inc. is headquartered in United States
- When did Cogent Biosciences, Inc. go public?
- Cogent Biosciences, Inc. initial public offering (IPO) was on March 29, 2018
- Is Cogent Biosciences, Inc. in the S&P 500?
- No, Cogent Biosciences, Inc. is not included in the S&P 500 index
- Is Cogent Biosciences, Inc. in the NASDAQ 100?
- No, Cogent Biosciences, Inc. is not included in the NASDAQ 100 index
- Is Cogent Biosciences, Inc. in the Dow Jones?
- No, Cogent Biosciences, Inc. is not included in the Dow Jones index
- When was Cogent Biosciences, Inc. last earnings report?
- Cogent Biosciences, Inc.'s most recent earnings report was on August 10, 2026
- When does Cogent Biosciences, Inc. report earnings?
- The next expected earnings date for Cogent Biosciences, Inc. is November 3, 2026
Data Sources & References
- COGT Official Website www.cogentbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1622229/000119312526053334/0001193125-26-053334-index.htm
- COGT Profile on Yahoo Finance finance.yahoo.com/quote/COGT
- COGT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cogt